(Q33702355)
Statements
1 reference
Rationale and design of the DIPAK 1 study: a randomized controlled clinical trial assessing the efficacy of lanreotide to Halt disease progression in autosomal dominant polycystic kidney disease (English)
1 reference
Ron T Gansevoort
1 reference
Esther Meijer
1 reference
Niek F Casteleijn
1 reference
Joost P H Drenth
1 reference
Hedwig d'Agnolo
1 reference
Johan W de Fijter
1 reference
Tom J Gevers
1 reference
Peter Kappert
1 reference
Dorien J M Peters
1 reference
Mahdi Salih
1 reference
Darius Soonawala
1 reference
Edwin M Spithoven
1 reference
Vicente E Torres
1 reference
Folkert W Visser
1 reference
Jack F M Wetzels
1 reference
Robert Zietse
1 reference
DIPAK Consortium
1 reference
15 December 2013
1 reference
1 reference
63
1 reference
446-455
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
Identifiers
1 reference
1 reference
1 reference